DrugDashboards

Fenofibrate

Fenofibrate · FENOFIBRATE 48 mg/1 · Tablet, Film Coated · Oral · Camber Pharmaceuticals, Inc.

NDC 31722-0595-90 · 90 TABLET, FILM COATED in 1 BOTTLE · ANDA · View full market →

The short version

18 companies supply this market — deep enough that no single failure threatens the supply. The price is down 15% over the past year, to $0.0814 per unit. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$0.0814per EAinvoice-surveyed acquisition cost · Aug 19, 2026
  • Part D plans paid (avg)$0.4067per dosage unitgross, before rebates — matched by drug name · 2024
  • Medicaid generic ceiling (FUL)$0.0814per TABweighted avg manufacturer price $0.0331 · Aug 1, 2026100% of what pharmacies pay — higher than 10% of drugs with this benchmark

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.2$0.4$0.6Apr 2017Sep 2026$0.0814
114 price points · per EA · dashed = manufacturer avg (WAMP)Source: CMS NADAC

Estimated fill cost

#30 count
$2.44
#90 count
$7.32

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Medicaid spend (2025)

$334,136
28,620 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

0● Low risk

Nothing here is signaling trouble: several manufacturers, no current shortage, no recent serious recalls, stable pricing. In drug supply, boring is the good outcome.

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.2%chance of a new FDA shortage posting for fenofibrate (oral solid) in the next 90 days

OAI inspection at a producing facility (24 months) · sole-source market · 1 Class I/II recall(s) in 12 months

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA204598
TE code
AB
Approval date
Jul 12, 2016
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

  • Class III · TerminatedSep 12, 2018
    Hetero Labs, Ltd. - Unit III — Presence of Foreign Tablet/Capsule: A foreign identified as Valacyclovir tablet 500 mg was co-mingled in a bottle containing Fenofibrate Tablets, USP 145 mg.

Manufacturers of Fenofibrate (Tablet, Film Coated)

LabelerStrengthFirst seenLast seen
A-S Medication SolutionsFENOFIBRATE 145 mg/1Jul 15, 2026Sep 3, 2026
A-S Medication SolutionsFENOFIBRATE 160 mg/1Jul 15, 2026Sep 3, 2026
Alembic Pharmaceuticals Inc.FENOFIBRATE 54 mg/1Jul 15, 2026Sep 3, 2026
Bryant Ranch PrepackFENOFIBRATE 145 mg/1Jul 15, 2026Sep 3, 2026
Remedyrepack Inc.FENOFIBRATE 54 mg/1Aug 6, 2026Sep 3, 2026
Westminster Pharmaceuticals, LLCFENOFIBRATE 160 mg/1Jul 15, 2026Sep 3, 2026
A-S Medication SolutionsFENOFIBRATE 54 mg/1Jul 15, 2026Sep 2, 2026
A-S Medication SolutionsFENOFIBRATE 48 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals Inc.FENOFIBRATE 145 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals Inc.FENOFIBRATE 48 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals LimitedFENOFIBRATE 145 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals LimitedFENOFIBRATE 48 mg/1Jul 15, 2026Sep 2, 2026
American Health PackagingFENOFIBRATE 54 mg/1Jul 15, 2026Sep 2, 2026
American Health PackagingFENOFIBRATE 160 mg/1Jul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedFENOFIBRATE 54 mg/1Jul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedFENOFIBRATE 160 mg/1Jul 15, 2026Sep 2, 2026
AvKAREFENOFIBRATE 160 mg/1Jul 15, 2026Sep 2, 2026
AvKAREFENOFIBRATE 145 mg/1Jul 15, 2026Sep 2, 2026
Bostal LLCFENOFIBRATE 54 mg/1Jul 15, 2026Sep 2, 2026
Bostal LLCFENOFIBRATE 145 mg/1Jul 15, 2026Sep 2, 2026
Bostal LLCFENOFIBRATE 160 mg/1Jul 15, 2026Sep 2, 2026
Bostal LLCFENOFIBRATE 48 mg/1Jul 15, 2026Sep 2, 2026
Bryant Ranch PrepackFENOFIBRATE 48 mg/1Jul 15, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.FENOFIBRATE 48 mg/1Jul 15, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.FENOFIBRATE 145 mg/1Jul 15, 2026Sep 2, 2026
Chartwell RX, LLCFENOFIBRATE 54 mg/1Jul 15, 2026Sep 2, 2026
Chartwell RX, LLCFENOFIBRATE 160 mg/1Jul 15, 2026Sep 2, 2026
Dr. Reddy's Laboratories Inc.FENOFIBRATE 160 mg/1Jul 15, 2026Sep 2, 2026
Dr. Reddy's Laboratories Inc.FENOFIBRATE 54 mg/1Jul 15, 2026Sep 2, 2026
Golden State Medical Supply, Inc.FENOFIBRATE 145 mg/1Jul 15, 2026Sep 2, 2026
Golden State Medical Supply, Inc.FENOFIBRATE 48 mg/1Jul 15, 2026Sep 2, 2026
Golden State Medical Supply, Inc.FENOFIBRATE 54 mg/1Jul 15, 2026Sep 2, 2026
Laurus Labs LimitedFENOFIBRATE 160 mg/1Jul 15, 2026Sep 2, 2026
Laurus Labs LimitedFENOFIBRATE 54 mg/1Jul 15, 2026Sep 2, 2026
Leading Pharma, LLCFENOFIBRATE 54 mg/1Jul 15, 2026Sep 2, 2026
Leading Pharma, LLCFENOFIBRATE 160 mg/1Jul 15, 2026Sep 2, 2026
Mylan Institutional Inc.FENOFIBRATE 48 mg/1Jul 15, 2026Sep 2, 2026
Mylan Institutional Inc.FENOFIBRATE 145 mg/1Jul 15, 2026Sep 2, 2026
Mylan Pharmaceuticals Inc.FENOFIBRATE 48 mg/1Jul 15, 2026Sep 2, 2026
Mylan Pharmaceuticals Inc.FENOFIBRATE 145 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Fenofibrate — NDC 31722-0595-90," retrieved September 3, 2026, https://drugdashboards.com/drug/31722059590.

Free to cite with attribution — see how the data is put together.